Slides on SGLT2 Inhibitor Therapy in Type 2 Diabetes

Learn about the role of SGLT-2 inhibitors in treating type 2 diabetes.
Anne Peters, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.96 MB
Released: December 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an independent educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.

Related Content

Learn from an expert about emerging strategies for combination treatment for NASH with GLP-1 receptor agonists plus SGLT2 inhibitors, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Released: February 2, 2023

Expert answers to learner questions from a live symposium with simulcast about strategies for a proactive approach to obesity management, from Clinical Care Options (CCO)

Caroline Apovian, MD Ken Fujioka, MD Released: January 13, 2023

Learn from an expert about the use of setmelanotide for hunger and weight management in pediatric patients with Bardet-Biedl syndrome, from Clinical Care Options (CCO)

Stephanie Sisley, MD Released: January 9, 2023

Hear from an expert on how to incorporate incretin-based therapies to address obesity and cardiovascular disease in your practice, from Clinical Care Options (CCO)

person default Lisa Coco, MSN, CRNP, CDCES Released: January 9, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings